全文获取类型
收费全文 | 616篇 |
免费 | 32篇 |
国内免费 | 42篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 19篇 |
妇产科学 | 3篇 |
基础医学 | 81篇 |
口腔科学 | 13篇 |
临床医学 | 83篇 |
内科学 | 185篇 |
皮肤病学 | 4篇 |
神经病学 | 13篇 |
特种医学 | 193篇 |
外科学 | 16篇 |
综合类 | 10篇 |
预防医学 | 20篇 |
眼科学 | 1篇 |
药学 | 20篇 |
中国医学 | 1篇 |
肿瘤学 | 23篇 |
出版年
2020年 | 2篇 |
2019年 | 4篇 |
2018年 | 5篇 |
2016年 | 2篇 |
2015年 | 13篇 |
2014年 | 9篇 |
2013年 | 13篇 |
2012年 | 2篇 |
2011年 | 6篇 |
2010年 | 13篇 |
2009年 | 18篇 |
2008年 | 8篇 |
2007年 | 34篇 |
2006年 | 13篇 |
2005年 | 15篇 |
2004年 | 2篇 |
2003年 | 8篇 |
2002年 | 12篇 |
2001年 | 10篇 |
2000年 | 2篇 |
1999年 | 11篇 |
1998年 | 36篇 |
1997年 | 35篇 |
1996年 | 38篇 |
1995年 | 30篇 |
1994年 | 47篇 |
1993年 | 24篇 |
1992年 | 8篇 |
1991年 | 9篇 |
1990年 | 12篇 |
1989年 | 37篇 |
1988年 | 35篇 |
1987年 | 35篇 |
1986年 | 26篇 |
1985年 | 20篇 |
1984年 | 16篇 |
1983年 | 12篇 |
1982年 | 10篇 |
1981年 | 7篇 |
1980年 | 8篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1977年 | 7篇 |
1976年 | 9篇 |
1975年 | 5篇 |
1974年 | 2篇 |
1973年 | 3篇 |
1972年 | 3篇 |
1971年 | 2篇 |
1970年 | 3篇 |
排序方式: 共有690条查询结果,搜索用时 0 毫秒
101.
102.
Scintigraphy in 3 patients with chondroblastoma showed that the tumors were hyperemic and avidly accumulated the radionuclide. These changes were also present in adjacent normal bone, but to a lesser degree. This suggest that radionuclide uptake in chondroblastoma is a function of the blood supply to the tumor rather than primary matrix extraction. 相似文献
103.
104.
The authors report a case of a hepatic artery aneurysm that simulated a mass in the head of the pancreas. The correct diagnosis was made preoperatively based on several findings: curvilinear calcification within the mass on CT, a well-defined cystic collection on ultrasound, absence of biliary duct dilatation or jaundice, and presence of other aneurysms. 相似文献
105.
106.
107.
108.
109.
110.
BackgroundRheumatoid arthritis is the most common chronic inflammatory disease in the UK. Serological status such as rheumatoid factor (RF) and anti-citrullinated peptide antibody (ACPA) positivity predict poor outcomes. Early intensive treatment regimens targeting remission reduce disease activity, structural damage, and long-term disability. However, we do not know whether all patients with active disease should have such intensive treatment regimens. Can serological status be used to predict the need for intensive therapy?MethodsWe analysed samples from a published randomised controlled trial which compared four treatment regimens in patients with early active rheumatoid arthritis (disease duration <2 years): methotrexate monotherapy, double therapy (methotrexate plus either ciclosporin or prednisolone), and triple therapy (methotrexate plus ciclosporin plus prednisolone). The trial randomised 467 patients (68% female, median age 54 years [IQR 46–63]). Disease activity was assessed with the disease activity score of 28 joints (DAS28). Remission was defined as DAS28 less than 2·6 at 24 months. RF isotypes (IgM and IgA) and ACPA levels were measured with commercial ELISA kits. Statistical analysis used Pearson's chi-squared test.Findings402 (86%) patients were positive for IgM RF, 346 (74%) for IgA RF, and 346 (74%) for ACPA. 98 (21%) patients achieved remission at 24 months. In RF IgM negative cases (n=65) the proportion of patients achieving remission at 24 months was similar in all treatment groups (25%, 22%, and 30% for monotherapy, double therapy, and triple therapy, respectively). In RF IgM positive cases, significantly fewer patients achieved remission with monotherapy (13/65, 17%) and double therapy (24/157, 15%) than with triple therapy (27/80, 34%) (p=0·001). There were similar, consistent findings with IgA RF and ACPA, with significantly more seropositive patients achieving remission with triple therapy than with monotherapy.InterpretationContemporary treatment of rheumatoid arthritis emphasises the use of intensive therapy to achieve remission. However, we have shown that not all patients require such an aggressive approach to therapy. Given the heterogeneity of the diease, treatment should be personalised to the individual, which would minimise costs of treatment as well as potentially toxic side-effects. Our study shows that only seropositive patients with rheumatoid arthritis should be given more intensive therapies.FundingNational Institute for Health Research. 相似文献